Questions About Cancer? 1-800-4-CANCER
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Head and Neck Steering Committee

The NCI Head and Neck Steering Committee (HNSC) was established in 2007. The HNSC is currently composed of the Steering Committee and three task forces. Members of HNSC include committee co-chairs, representatives from the Cooperative Groups, Specialized Programs of Research Excellence (SPOREs), community oncologists, biostatisticians, pathologists, patient advocates, and NCI staff.

Mission Statement

The HNSC functions to harmonize an efficient, cost-effective, science-driven, and transparent process that will identify and promote the "Best Science" in head and neck clinical research by addressing the design and prioritization of phase III trials in head and neck cancer and large phase II studies.

Roster of Head and Neck Steering Committee (HNSC) members
Ezra Cohen, M.D., Brian O'Sullivan, M.B., and Robert Ferris, M.D., Ph.D., Co-chairs

Task Forces

  • Metastatic/Recurrent Disease: Christine Chung, M.D. and Brian Nussenbaum, M.D., Co-chairs
  • Previously-untreated Locally Advanced Disease: Avraham Eisbruch, M.D. and A. Dimitrios Colevas, M.D., Co-chairs
  • Rare Tumors: Rita Axelrod, M.D.and Erich M. Sturgis, M.D., M.P.H., Co-chairs

Clinical Trials Planning Meetings (CTPMs)

The Goal of CTPMs is to:

  • identify strategic directions for clinical trials in a specific field
    • reach consensus on the most important clinical trials to conduct;
    • identify portfolio gaps and emerging scientific opportunities;
    • identify innovative trial design opportunities;
  • facilitate innovation and collaboration among the broad oncology community active in the specific cancer under study

List of Clinical Trial Planning Meetings (CTPM) Executive Summaries and Publications


To search all active clinical trials, go to:

CCCT Contact: Jean M. Lynn, RN, M.P.H., OCN